PanTera
PanTera
Agent38Agent Readiness: 38/100. Below median. Measured by StartupHub.ai. Median 41.Focuses on producing actinium-225, a rare radioisotope used in targeted alpha therapies for cancer.
About
PanTera is a Belgian company focused on the large-scale, reliable production of Actinium-225 (Ac-225), a scarce radioisotope critical for emerging targeted alpha therapies in cancer treatment. They are constructing a state-of-the-art production facility in Mol, Belgium, utilizing a proprietary process to transform Radium-226 into high-purity Ac-225.
Key facts
At-a-glance profile data
- Website
- pantera-life.com
- Headquarters
- Mol, Belgium
- Founded
- 2022
- Employees
- 58
- Total funding
- $122M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2024 | Series A | $108M | EQT Life Sciences |
| 1 Jan 2022 | Seed | $14M | - |
Tech stack
Detected on pantera-life.com, last scanned 18 Sept 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- Tailwind CSS
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has PanTera raised?
PanTera has raised a total of $122M in funding. The most recent round on record is Series A.
How many employees does PanTera have?
PanTera has approximately 58 people on record.